Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 67046-1599

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 67046-1599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coupler Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (27241 155 04 Oxybutynin Er 5mg 67046 1599 30)

Label (27241 155 04 Oxybutynin Er 5mg 67046 1599 30)
This is a description of Oxybutynin Chloride, a medication available in tablet form. Each tablet contains 5mg of Oxybutynin Chloride in extended-release form. The tablets are packaged by Coupler LLC and have a shelf life until March 23, 2026. The usual dosage information is provided in the package insert. It is recommended to store the medication at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). Additionally, the GTIN code and batch information is available for reference.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.